908 Devices (MASS) to Release Earnings on Tuesday

908 Devices (NASDAQ:MASS) is expected to be announcing its earnings results before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $17.05 million for the quarter.

908 Devices Stock Up 0.8 %

908 Devices stock opened at $2.55 on Tuesday. The firm’s 50-day simple moving average is $2.40 and its 200 day simple moving average is $3.01. 908 Devices has a 52 week low of $1.81 and a 52 week high of $7.91. The firm has a market capitalization of $88.79 million, a PE ratio of -1.44 and a beta of 0.99.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on MASS shares. Stephens reissued an “overweight” rating and issued a $6.00 price objective on shares of 908 Devices in a research report on Wednesday, January 15th. Leerink Partners restated a “market perform” rating and set a $4.00 price objective (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of 908 Devices in a research note on Wednesday, February 19th. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Finally, Stifel Nicolaus decreased their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $5.33.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.